In an exciting breakthrough, Corinne Hazel, an undergraduate studying environmental microbiology at West Virginia University (WVU), has discovered a new species of fungus hidden within morning glory plants. This remarkable find, named Periglandula clandestina, is believed to be the elusive fungus that scientists, including the renowned chemist Albert Hofmann, have been searching for since the 1930s.
Hofmann, who first synthesized LSD, theorized that morning glory plants might contain a fungus that produces compounds similar to those found in ergot, the source of lysergic acid. Despite extensive searches over the decades, this potential link remained unverified until Hazel's serendipitous discovery.
While examining morning glory seeds for protective chemicals, Hazel stumbled upon a peculiar white fuzz. Intrigued, she collected samples and, with the guidance of her faculty mentor, Professor Daniel Panaccione, sequenced the DNA. The results confirmed the presence of a previously unknown species of ergot-producing fungus.
"I feel incredibly fortunate to have discovered this," Hazel remarked. "It's astonishing that something so significant could emerge from a simple observation."
The Hidden Potential of Morning Glory
Daniel Panaccione emphasized the significance of this discovery, noting that morning glory plants contain high concentrations of lysergic acid derivatives, which contribute to their psychedelic properties. Previous studies indicated that many morning glory species might harbor ergot-related fungi, but until now, the specific fungus remained a mystery.
Ergot alkaloids, produced by fungi like Claviceps purpurea, have a complex history in medicine. While they can be toxic in high doses, they have also been utilized in treating migraines and managing conditions such as Parkinson's disease. Panaccione noted, "Many substances have medicinal value when administered correctly or modified."
A Promising Future
The implications of Hazel's discovery extend beyond historical curiosity. Early indications suggest that P. clandestina might produce ergot alkaloids in significant quantities, paving the way for potential pharmaceutical applications. Hazel is now focused on cultivating this slow-growing fungus and investigating whether related species exist within other morning glory varieties.
This discovery not only sheds light on a historical scientific quest but also holds the promise of advancing medical research. As Hazel reflects on her journey, she acknowledges the importance of recognizing and seizing opportunities in scientific exploration. "I'm very proud of the work I've accomplished at WVU," she stated.
As research continues, the future may reveal more about the hidden world of fungi and their potential to transform medicine.
The findings were published in the journal Mycologia.